North America Dry Eye Product Market to 2027- Covid-19 Impact and Regional Analysis by product ; Type ;and Country

September 2020 •
96 pages •
Report ID: 5978896 •
Format: PDF

Summary
Table of contents
Search Inside

The North America Dry Eye Product market is expected to reach US$ 4167.39 million by 2027 from US$ 2870.12 million in 2019. The market is estimated to grow with a CAGR of 5.0% from 2020 to 2027.

The growth of the market is driven by factors such as the growing the incidences and case of dry eye as well as rising the geriatric population across the globe. However, high significant amount of side effects of dry eye products and COVID-19 pandemic is likely to restrain the market growth to a certain extent.
Dry eye is a chronic syndrome and is a progressive depending upon the cause and severity.It is a condition when a person does not have tears to lubricate his or her eyes.

Tears are an essential part of maintaining good health of the eye and assist in providing good vision.The syndrome is commonly seen among older people and is becoming common among people spending a long time in front of the computer.

The factors that can cause dry eye include age, medications, environmental conditions, long term use of contact lenses. The conditions cannot be cured completely; however, it can be managed by using medical products.

So to treat such an unavoidable condition dry eye products and accessories being commonly used the products restores the water into the eye sack and lubrication takes up and condition retrieves. Now a days changing lifestyle among the people is the common cause of developing dry eye which ultimately boosts the demand for this segment product.

The products are been designed according to the need of a condition such as artificial drops, antibiotic drops, hormone drops.
Based on Product the North America Dry Eye Product is segmented into Artificial drops, Antibiotic drops, Hormone drops and others.Among which artificial drops segment held the largest share in year 2019 and is expected to show its dominance during forecast period.

And Hormone drops segment held the highest CAGR rate during the forecast period.

Based on type it is segmented into OTC drugs and prescription drugs.Among which OTC drugs segment held the largest share in year 2019 and is expected to maintain its dominance during forecast period.

And prescription drugs expected to have highest CAGR during during forecast period.

Ahmad helps you find the right report:

+1 718 618 4302
Contact by email

FAQ

Testimonials

The market research advisor answered my questions quickly and professionally. ReportBuyer's team did their best to ensure that I felt comfortable before making the investment to purchase the report.

Cristian Nunez

Director of Corporate Development Chugach Alaska Corporation

My overall experience with ReportBuyer today has been very positive, and I must thank you for your patience (...). Also, the sample you sent me and the explanations provided were very helpful.

D. Lescuyer

Executive Vice President Oral Business at Skyepharma

The research specialist was very helpful, and proposed the best content for my needs. ReportBuyer also offered a great follow-up, thanks for everything !

P. Thompson

EMEA Managing Director

We were satisfied with the support that ReportBuyer's team provided. Thanks to their recommendations, the report we purchased provided exactly what we want.

Y. Wang

Business Analyst

We didn't have time to do the research internally, and thanks to ReportBuyer's team we were able to find the appropriate data.

S. Chen

Research Coordinator

I was impressed by the customer service: it was fast, responsive, and 100% professional !

D. Krivan

Market Research Analyst

The research specialist provided prompt and helpful service. He also followed up to ensure I had all the information to deliver my business development plan.

C. Adams

Senior Business Development Manager